NEW YORK – Fujifilm Medical Systems said this week that it will integrate Fujifilm Wako Diagnostics into its business, effective Oct. 1. As a result, Fujifilm Wako’s portfolio of in vitro diagnostic products will be added to Fujifilm Medical’s product offerings. Wako Diagnostics was originally acquired by Fujifilm in 2017 and has been operating as a separate subsidiary.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.